Orgenesis Inc.
NASDAQ:ORGS
1.2 (USD) • At close October 29, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Orgenesis Inc. |
Symbool | ORGS |
Munteenheid | USD |
Prijs | 1.2 |
Beurswaarde | 5,724,936 |
Dividendpercentage | 0% |
52-weken bereik | 1.03 - 10.8 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Vered Caplan M.Sc. |
Website | https://www.orgenesis.com |
An error occurred while fetching data.
Over Orgenesis Inc.
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)